FDA Inspection 1122522 — Charles River Laboratories Cleveland, Inc.

Charles River Laboratories Cleveland, Inc. — FEI 3004063414

The FDA completed an inspection of Charles River Laboratories Cleveland, Inc. on February 19, 2020 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 19, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cleveland, OH (United States)